Cisplatin, epirubicin and 5-fluorouracil combination chemotherapy for recurrent carcinoma of the salivary gland

M. Airoldi, F. Pedani, V. Brando, P. Gabriele, C. Giordano

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)252-256
Number of pages5
JournalTumori
Volume75
Issue number3
Publication statusPublished - 1989

ASJC Scopus subject areas

  • Cancer Research

Cite this

Cisplatin, epirubicin and 5-fluorouracil combination chemotherapy for recurrent carcinoma of the salivary gland. / Airoldi, M.; Pedani, F.; Brando, V.; Gabriele, P.; Giordano, C.

In: Tumori, Vol. 75, No. 3, 1989, p. 252-256.

Research output: Contribution to journalArticle

Airoldi, M, Pedani, F, Brando, V, Gabriele, P & Giordano, C 1989, 'Cisplatin, epirubicin and 5-fluorouracil combination chemotherapy for recurrent carcinoma of the salivary gland', Tumori, vol. 75, no. 3, pp. 252-256.
Airoldi, M. ; Pedani, F. ; Brando, V. ; Gabriele, P. ; Giordano, C. / Cisplatin, epirubicin and 5-fluorouracil combination chemotherapy for recurrent carcinoma of the salivary gland. In: Tumori. 1989 ; Vol. 75, No. 3. pp. 252-256.
@article{5ec79f6068da4b0bba3ba1c48d14c8c1,
title = "Cisplatin, epirubicin and 5-fluorouracil combination chemotherapy for recurrent carcinoma of the salivary gland",
author = "M. Airoldi and F. Pedani and V. Brando and P. Gabriele and C. Giordano",
year = "1989",
language = "English",
volume = "75",
pages = "252--256",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "3",

}

TY - JOUR

T1 - Cisplatin, epirubicin and 5-fluorouracil combination chemotherapy for recurrent carcinoma of the salivary gland

AU - Airoldi, M.

AU - Pedani, F.

AU - Brando, V.

AU - Gabriele, P.

AU - Giordano, C.

PY - 1989

Y1 - 1989

UR - http://www.scopus.com/inward/record.url?scp=0024378072&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024378072&partnerID=8YFLogxK

M3 - Article

C2 - 2475951

AN - SCOPUS:0024378072

VL - 75

SP - 252

EP - 256

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 3

ER -